Continuous Glucose Monitoring-Driven Personalization of Cornstarch Therapy in Glycogen Storage Disease: A Retrospective Analysis
A simple glucose-monitoring approach tailors starch therapy for glycogen storage patients, improving nighttime safety without new drugs.
This retrospective analysis of 32 pediatric/adult GSD patients demonstrates that a CGM-guided framework for individualizing cornstarch therapy maintains metabolic stability, normal growth, and liver enzyme control while enabling targeted correction of nocturnal hypoglycemia episodes. The approach provides a practical, immediately implementable improvement to GSD management without requiring new therapeutics.
What the study was
- Study design
- Retrospective cohort study
- Population
- Patients with hepatic glycogen storage disease (GSD types Ia, Ib, IXa) receiving cornstarch therapy
- Sample size
- 32
- Category
- Diagnostics
- Maturity
- Exploratory
- Journal
- Yonsei Medical Journal
Why it surfaced
Practical CGM-guided optimization of standard-of-care for rare disease with hypoglycemia risk; near-term implementable framework; retrospective N=32 limits evidence level.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.